Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial.
Saved in:
| Title: | Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial. |
|---|---|
| Authors: | Yuan, Meng-Qi1,2 (AUTHOR), Song, Le3 (AUTHOR), Wang, Ze-Rui1,4 (AUTHOR), Zhang, Zi-Ying1,2 (AUTHOR), Shi, Ming1,2 (AUTHOR), He, Junli3 (AUTHOR), Mo, Qiong3 (AUTHOR), Zheng, Ning3 (AUTHOR), Yao, Wei-Qi5,6,7 (AUTHOR), Zhang, Yu5,6 (AUTHOR), Dong, Tengyun5 (AUTHOR), Li, Yuanyuan1 (AUTHOR), Zhang, Chao1 (AUTHOR), Song, Jinwen1 (AUTHOR), Huang, Lei1 (AUTHOR), Xu, Zhe1 (AUTHOR), Yuan, Xin1 (AUTHOR), Fu, Jun-Liang1 (AUTHOR), Zhen, Cheng1 (AUTHOR), Cai, Jianming8 (AUTHOR) |
| Source: | Stem Cell Research & Therapy. 2/25/2025, Vol. 16 Issue 1, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17576512 |
|---|---|
| DOI: | 10.1186/s13287-025-04148-1 |
